Related Experiment Video

Updated: Aug 23, 2026

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
15:48

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

Unraveling the mechanisms involved in motor neuron degeneration in ALS

Lucie I Bruijn1, Timothy M Miller, Don W Cleveland

  • 1ALS Association, Guilford, Connecticut 06437, USA. lbruijn@snet.net

Annual Review of Neuroscience
|June 26, 2004
PubMed

Insights

Amyotrophic lateral sclerosis (ALS) pathogenesis remains unclear, but genetic mutations like SOD1 are key. Research models now explore motor neuron death mechanisms and potential therapies.

Area of Science:

  • Neuroscience
  • Genetics
  • Motor Neuron Diseases

Background:

  • Amyotrophic lateral sclerosis (ALS) is a progressive, fatal motor neuron disease with unknown mechanisms.
  • Despite Charcot's description over 130 years ago, effective treatments are lacking.

Purpose of the Study:

  • To elucidate the mechanisms underlying selective motor neuron degeneration in ALS.
  • To explore genetic contributors and potential therapeutic strategies for ALS.

Main Methods:

  • Utilizing genetic insights to identify causative and contributing genes (e.g., SOD1, neurofilaments, VEGF).
  • Developing and employing model systems to test disease hypotheses.
  • Investigating the role of synaptic glutamate handling and excitotoxicity.

Main Results:

  • Mutations in Cu/Zn superoxide dismutase (SOD1) identified as a primary cause of ALS.
  • Other genes (neurofilaments, dynactin, VEGF) implicated in motor neuron diseases.
  • Model systems highlight the involvement of nonneuronal cells in disease progression.

Conclusions:

  • Genetic discoveries have advanced understanding of ALS pathogenesis.
  • Model systems offer avenues for testing novel therapeutic strategies.
  • Addressing glutamate excitotoxicity and nonneuronal cell involvement presents new treatment possibilities.

More Related Videos

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis08:59

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis

Published on: July 16, 2021

Modeling Charcot-Marie-Tooth Disease In Vitro by Transfecting Mouse Primary Motoneurons07:43

Modeling Charcot-Marie-Tooth Disease In Vitro by Transfecting Mouse Primary Motoneurons

Published on: January 7, 2019

Related Concept Videos

Cross-bridge Cycle01:26

Cross-bridge Cycle

As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...